Melvin E. Klegerman

2.6k total citations
85 papers, 2.1k citations indexed

About

Melvin E. Klegerman is a scholar working on Biomedical Engineering, Molecular Biology and Surgery. According to data from OpenAlex, Melvin E. Klegerman has authored 85 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Biomedical Engineering, 21 papers in Molecular Biology and 16 papers in Surgery. Recurrent topics in Melvin E. Klegerman's work include Photoacoustic and Ultrasonic Imaging (29 papers), Ultrasound and Hyperthermia Applications (27 papers) and Coronary Interventions and Diagnostics (10 papers). Melvin E. Klegerman is often cited by papers focused on Photoacoustic and Ultrasonic Imaging (29 papers), Ultrasound and Hyperthermia Applications (27 papers) and Coronary Interventions and Diagnostics (10 papers). Melvin E. Klegerman collaborates with scholars based in United States, South Korea and India. Melvin E. Klegerman's co-authors include David D. McPherson, Shaoling Huang, Ashwin Nagaraj, Bonnie J. Kane, Christy K. Holland, Andrew J. Hamilton, Robert C. MacDonald, Hayat Alkan-Önyüksel, Shao-Ling Huang and Michael J. Groves and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Melvin E. Klegerman

84 papers receiving 2.1k citations

Peers

Countries citing papers authored by Melvin E. Klegerman

Since Specialization

Citations

This map shows the geographic impact of Melvin E. Klegerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melvin E. Klegerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melvin E. Klegerman more than expected).

Fields of papers citing papers by Melvin E. Klegerman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melvin E. Klegerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melvin E. Klegerman. The network helps show where Melvin E. Klegerman may publish in the future.

Co-authorship network of co-authors of Melvin E. Klegerman

This figure shows the co-authorship network connecting the top 25 collaborators of Melvin E. Klegerman. A scholar is included among the top collaborators of Melvin E. Klegerman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melvin E. Klegerman. Melvin E. Klegerman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Absolute concentration estimation of COVID-19 convalescent and post-vaccination IgG antibodies 2024 ·PLoS ONE ·Melvin E. Klegerman, Tao Peng, (unknown), Mohammad H. Rahbar, Manouchehr Hessabi, Amirali Tahanan, Audrey Wanger, Carolyn Z. Grimes, Luis Ostrosky‐Zeichner, (unknown), Jeffrey D. Cirillo, (unknown), (unknown), David D. McPherson	1
2	Initiating and imaging cavitation from infused echo contrast agents through the EkoSonic catheter 2023 ·Scientific Reports ·(unknown), Maxime Lafond, Kevin J. Haworth, (unknown), Dan Ionascu, (unknown), Shaoling Huang, Melvin E. Klegerman, Tao Peng, David D. McPherson, (unknown), Christy K. Holland	10
3	Storage Stability of Atheroglitatide, an Echogenic Liposomal Formulation of Pioglitazone Targeted to Advanced Atheroma with a Fibrin-Binding Peptide 2023 ·Pharmaceutics ·Melvin E. Klegerman, Tao Peng, Shaoling Huang, (unknown), Melanie R. Moody, (unknown), David D. McPherson	0
4	Thrombolytic efficacy and enzymatic activity of rt-PA-loaded echogenic liposomes 2015 ·Journal of Thrombosis and Thrombolysis ·Kenneth B. Bader, Guillaume Bouchoux, Tao Peng, Melvin E. Klegerman, David D. McPherson, Christy K. Holland	23
5	Nitric Oxide Pretreatment Enhances Atheroma Component Highlighting in Vivo with Intercellular Adhesion Molecule-1-Targeted Echogenic Liposomes 2014 ·Ultrasound in Medicine & Biology ·Patrick Kee, Hyunggun Kim, Shaoling Huang, Susan T. Laing, Melanie R. Moody, Deborah Vela, Melvin E. Klegerman, David D. McPherson	13
6	The impact of bubbles on measurement of drug release from echogenic liposomes 2012 ·Ultrasonics Sonochemistry ·Jonathan A. Kopechek, Kevin J. Haworth, Kirthi Radhakrishnan, Shao-Ling Huang, Melvin E. Klegerman, David D. McPherson, Christy K. Holland	23
7	Stability of Echogenic Liposomes as a Blood Pool Ultrasound Contrast Agent in a Physiologic Flow Phantom 2012 ·Ultrasound in Medicine & Biology ·Kirthi Radhakrishnan, Kevin J. Haworth, Shao-Ling Huang, Melvin E. Klegerman, David D. McPherson, Christy K. Holland	22
8	Fibrin Targeting of Echogenic Liposomes with Inactivated Tissue Plasminogen Activator 2008 ·Journal of Liposome Research ·Melvin E. Klegerman, (unknown), David D. McPherson	38
9	Intravascular ultrasound molecular imaging of atheroma components in vivo 2004 ·Journal of the American College of Cardiology ·Andrew J. Hamilton, Shaoling Huang, (unknown), Mark Rabbat, Bonnie J. Kane, Ashwin Nagaraj, Melvin E. Klegerman, David D. McPherson	159
10	Novel Echogenic Drug-Immunoliposomes for Drug Delivery 2004 ·Investigative Radiology ·Susan Tiukinhoy, (unknown), Shaoling Huang, Melvin E. Klegerman, Robert C. MacDonald, David D. McPherson	29
11	Quantitative Immunoblot Assay for Assessment of Liposomal Antibody Conjugation Efficiency 2002 ·Analytical Biochemistry ·Melvin E. Klegerman, Andrew J. Hamilton, Shaoling Huang, Susan Tiukinhoy, (unknown), Robert C. MacDonald, David D. McPherson	25
12	Development of Echogenic, Plasmid-Incorporated, Tissue-Targeted Cationic Liposomes that Can Be Used for Directed Gene Delivery 2000 ·Investigative Radiology ·Susan Tiukinhoy, (unknown), Vera P. Shively, Ashwin Nagaraj, Bonnie J. Kane, Melvin E. Klegerman, Robert C. MacDonald, David D. McPherson, Jon S. Matsumura	39
13	In vivo targeting of acoustically reflective liposomes for intravascular and transvascular ultrasonic enhancement 1999 ·Journal of the American College of Cardiology ·(unknown), Hayat Alkan-Önyüksel, Bonnie J. Kane, Kishin Ramani, Ashwin Nagaraj, Rodney Greene, Melvin E. Klegerman, David D. McPherson	177
14	In Vitro Targeting of Acoustically Reflective Immunoliposomes to Fibrin Under Various Flow Conditions 1998 ·Journal of drug targeting ·(unknown), (unknown), Melvin E. Klegerman, Ashwin Nagaraj, David D. McPherson, Hayat Önyüksel	35
15	Chemical and ultrastructural investigations ofMycobacterium bovisBCG: implications for the molecular structure of the mycobacterial cell envelope 1996 ·FEMS Immunology & Medical Microbiology ·Melvin E. Klegerman, (unknown), José Luis Velasco Garrido, Héctor Reyes, Michael J. Groves	6
16	Inhibition of Murine Sarcoma Cell Adherence to Polystyrene Substrata by Bacillus Calmette-Guérin: Evidence for Fibronectin-Mediated Direct Antitumor Activity of BCG 1993 ·Cancer Investigation ·Melvin E. Klegerman, (unknown), (unknown), (unknown), Michael J. Groves	6
17	High-dose inhibition and low-dose enhancement of murine sarcoma growth exhibited by BCG vaccine 1991 ·Cancer Letters ·Melvin E. Klegerman, (unknown), (unknown)	9
18	Cell mass of Mycobacterium bovis BCG estimated by gas chromatography 1990 ·Biologicals ·(unknown), Michael J. Groves, Melvin E. Klegerman	7
19	Teaching Pharmaceutical Biotechnology at the University of Illinois at Chicago 1988 ·American Journal of Pharmaceutical Education ·Michael J. Groves, Melvin E. Klegerman	2
20	Quantitation of IgG antibody to the type-specific polysaccharide of group B streptococcus type 1b in pregnant women and infected infants 1984 ·The Journal of Pediatrics ·Samuel P. Gotoff, Cynthia K. Papierniak, Melvin E. Klegerman, Kenneth M. Boyer	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact